OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Gastroenterology & Hepatology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
The clinical significance of serum HbA1c to diagnose diabetes mellitus during acute pancreatitis	153
Sleeve gastrectomy with transit bipartition: a review of the literature	78
The use of personal protective equipment in endoscopy: what should the endoscopist wear during a pandemic?	71
Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients	67
Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration	46
The evolution of clinical outcomes in metastatic pancreatic adenocarcinoma: a 10-year experience at a tertiary referral center	45
Managing pain in irritable bowel syndrome: current perspectives and best practice	35
Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting	30
Advances in understanding of biliary atresia pathogenesis and progression – a riddle wrapped in a mystery inside an enigma	24
A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients	21
Dual energy computed tomography in Crohn’s disease: a targeted review	20
Towards a better diagnosis of gastro esophageal reflux disease	19
Protective and therapeutic potential of melatonin against intestinal diseases: updated review of current data based on molecular mechanisms	19
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions	19
Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review	18
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art	17
Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices	16
Hemostatic powders and gels in gastrointestinal endoscopy: current perspective and future recommendations	16
Beta-adrenergic blockade in cirrhosis – harmful or helpful?	16
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis	15
Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications	15
Gallbladder carcinosarcoma: current perspectives and new development	15
Two-dimensional shear wave elastography for screening varices in Asian patients with primary biliary cholangitis	15
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis	15
Small bowel transplant – novel indications and recent progress	15

EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?	15
Detection methods of synchronous colorectal lesions in proximal colon for patients with obstructive colorectal cancer: a literature review	15
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors	14
Capsule endoscopy - a non-invasive modality to investigate the GI tract: out with the old and in with the new?	14
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?	14
Paraneoplastic syndromes in hepatocellular carcinoma: a review	14
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece	13
Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC)	12
Highlighting novel targets in immunotherapy for liver cancer	12
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview	12
Pneumatic dilation for the treatment of persistent post-laparoscopic fundoplication dysphagia: long-term efficacy and safety	12
Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on long-term survival	12
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases	12
Filgotinib for moderately to severely active ulcerative colitis	12
Clinical efficacy and safety of robot assisted surgery for choledochal cysts excisions: a systematic review and meta-analysis	12
Hepatitis B flare: the good, the bad and the ugly	12
Update of gut gas metabolism in ulcerative colitis	11
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study	11
Screening for pancreatic cancer has the potential to save lives, but is it practical?	10
Antireflux surgery – choosing the right candidate	10
Intra-arterial locoregional therapies for intrahepatic cholangiocarcinoma	10
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injury	10
CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis	10
Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective	10
Management of disease-related abdominal abscesses in Crohn’s disease	9
When to refer patients for liver elastography	9
Roles of nuclear receptors in hepatic stellate cells	9
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making	9
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation	9
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients	9
Cross-talk between immune system and microbiota in COVID-19	9
UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease	9
The role of videocapsule endoscopy in the diagnosis and follow-up of celiac disease: a scoping review	9
Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment	9
The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD)	8
Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication	8
New progress with calcium-binding protein S100A16 in digestive system disease	8
Elucidating the role of extracellular vesicles in liver injury induced by HIV	8
Training in endoscopic retrograde cholangio-pancreatography: a critical assessment of the broad scenario of training programs and models	8
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis	8
Therapeutic effect of ustekinumab on patients with extra-intestinal manifestations of Crohn’s disease	8
A true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication	8
NAFLD and renal function in children: is there a genetic link?	7
Endoscopic sleeve gastroplasty for metabolic dysfunction-associated steatotic liver disease	7
Updates in association of gastroesophageal reflux disease and dental erosion: systematic review	7
A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments	7
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences	7
Development and validation of a risk model to predict the progression of ulcerative colitis patients to acute severe disease within one year	7
Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives	7
Risankizumab to treat moderately to severely active Crohn’s disease in adults: an evaluation of trials and data	7

ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management	7
A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis	7
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?	7
Targeting liver metabolism: a pathway to cure hepatitis B virus?	7
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)	7
Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages	7
The role of microRNAs in the different phases of liver regeneration	7
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY	6
Randomized crossover trial of ‘Roll-over’ technique of abdominal paracentesis versus standard technique in suspected malignant ascites	6
AKI in ACLF: navigating the complex therapeutic puzzle	6
PSC associated inflammatory bowel disease: a distinct entity	6
Nonachalasic esophageal motor disorders, from diagnosis to therapy	6
Does adjuvant chemotherapy improve outcomes in elderly patients with colorectal cancer? A systematic review and meta-analysis of real-world studies	6
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma	6
The conundrum in endoscopic management of duodenal polyps: a tertiary cancer center experience	6
Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?	6
Achalasia, from diagnosis to treatment	6
Irritable bowel syndrome – controversies in diagnosis and management	6
Cirrhosis and non-hepatic surgery in 2023 – a precision medicine approach	6
The risk of aspirin induced postoperative hemorrhage: a systematic review and meta-analysis	6
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir	6
Risk factors for recurrent common bile duct stones: a systematic review and meta-analysis	6
Response to letter: ‘Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction’	6
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study	6
Hepatobiliary disease after bone marrow transplant	6
Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy	6